{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:44:25Z","timestamp":1773150265424,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.bbr.2010.11.029","type":"journal-article","created":{"date-parts":[[2010,11,21]],"date-time":"2010-11-21T09:11:43Z","timestamp":1290330703000},"page":"8-14","source":"Crossref","is-referenced-by-count":16,"title":["The benzodiazepine diazepam demonstrates the usefulness of Syrian hamsters as a model for anxiety testing: Evaluation of other classes of anxiolytics in comparison to diazepam"],"prefix":"10.1016","volume":"218","author":[{"given":"Robert L.","family":"Gannon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Lungwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Batista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Hester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Huntley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa","family":"Peacock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Delagrange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Millan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2010.11.029_bib0005","first-page":"11","article-title":"Distinct \u03b1 subunit variations of the hypothalamic GABAA receptor triplets (\u03b1\u03b2\u03b3) are linked to hibernating state in hamsters","volume":"6","author":"Al\u00f2","year":"2010","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.bbr.2010.11.029_bib0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1054-3589(08)57004-9","article-title":"Subtype-selective GABA(A) receptor modulation yields a novel pharmacological profile: the design and development of TPA023","volume":"57","author":"Atack","year":"2009","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.bbr.2010.11.029_bib0015","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.euroneuro.2008.06.002","article-title":"Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: a comparison to other agents","volume":"18","author":"Brocco","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2010.11.029_bib0020","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/jps.2600530602","article-title":"1,4-benzodiazepines","volume":"53","author":"Childress","year":"1964","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.bbr.2010.11.029_bib0025","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.2174\/138161208786848775","article-title":"Potential novel anxiolytic drugs","volume":"14","author":"Christmas","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bbr.2010.11.029_bib0030","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/YCO.0b013e32831a473d","article-title":"Current use of benzodiazepines in anxiety disorders","volume":"22","author":"Cloos","year":"2009","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.bbr.2010.11.029_bib0035","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.2174\/092986707782023190","article-title":"GABAA\/Bz receptor subtypes as targets for selective drugs","volume":"14","author":"Da Settimo","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bbr.2010.11.029_bib0040","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0028-3908(99)00268-3","article-title":"Citalopram reduces social interaction in rats by activation of serotonin (5-HT)(2C) receptors","volume":"39","author":"Dekeyne","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2010.11.029_bib0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1517\/14728214.9.1.9","article-title":"Potential therapeutic targets for neurokinin-1 receptor antagonists","volume":"9","author":"Duffy","year":"2004","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.bbr.2010.11.029_bib0050","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.2174\/138161209788168074","article-title":"Tachykinin receptors as therapeutic targets in stress-related disorders","volume":"15","author":"Ebner","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bbr.2010.11.029_bib0055","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejphar.2005.10.012","article-title":"The selective tachykinin neurokinin1 (NK1) receptor antagonist, GR 205,171, stereospecifically inhibits light-induced phase advances of hamster circadian activity rhythms","volume":"527","author":"Gannon","year":"2005","journal-title":"Eur J Pharm"},{"key":"10.1016\/j.bbr.2010.11.029_bib0060","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.brainres.2006.02.017","article-title":"The corticotropin-releasing factor (CRF)1 receptor antagonists CP154,526 and DMP695 inhibit light-induced phase advances of hamster circadian activity rhythms","volume":"1083","author":"Gannon","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2010.11.029_bib0065","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00213-007-0903-z","article-title":"Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms","volume":"195","author":"Gannon","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2010.11.029_bib0070","doi-asserted-by":"crossref","unstructured":"Gannon RL, Millan MJ. Positive and negative modulation of circadian activity rhythms by mGluR5 and mGluR2\/3 metabotropic glutamate receptors. Neuropharmacology; in press. doi:10.1016\/j.neuropharm.2010.08.022.","DOI":"10.1016\/j.neuropharm.2010.08.022"},{"key":"10.1016\/j.bbr.2010.11.029_bib0075","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.euroneuro.2009.06.011","article-title":"Differential influence of selective 5-HT5A vs 5-HT1A, 5-HT1B, or 5-HT2C receptor blockade upon light-induced phase shifts in circadian activity rhythms: interaction studies with citalopram","volume":"19","author":"Gannon","year":"2009","journal-title":"Eur Neuropsychopharm"},{"key":"10.1016\/j.bbr.2010.11.029_bib0080","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF02245224","article-title":"Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents","volume":"113","author":"Griebel","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2010.11.029_bib0085","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pharmthera.2007.03.007","article-title":"Neurosteroid modulation of synaptic and extrasynaptic GABA(A) receptors","volume":"116","author":"Herd","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bbr.2010.11.029_bib0090","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.pbb.2006.12.021","article-title":"Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression","volume":"86","author":"Hodgson","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2010.11.029_bib0095","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/187152707780619344","article-title":"The CRF1 receptor, a novel target for the treatment of depression, anxiety, and stress-related disorders","volume":"6","author":"Kehne","year":"2007","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.bbr.2010.11.029_bib0100","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1176\/appi.ajp.2008.08030395","article-title":"Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia","volume":"165","author":"Lewis","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2010.11.029_bib0105","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/hup.726","article-title":"Antidepressants and their effect on sleep","volume":"20","author":"Mayers","year":"2005","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"10.1016\/j.bbr.2010.11.029_bib0110","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0893-133X(01)00244-5","article-title":"Anxiolytic properties of the selective, non-peptidergic CRF1 antagonists, CP154,526 and DMP695: a comparison to other classes of anxiolytics agent","volume":"25","author":"Millan","year":"2001","journal-title":"Neuropsychopharm"},{"key":"10.1016\/j.bbr.2010.11.029_bib0115","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00213-008-1209-5","article-title":"An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters","volume":"200","author":"Moise","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2010.11.029_bib0120","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1017\/S1461145709990630","article-title":"Differential effects of acute and repeated citalopram in mouse models of anxiety and depression","volume":"13","author":"Mombereau","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2010.11.029_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresrev.2005.08.003","article-title":"The circadian visual system","volume":"51","author":"Morin","year":"2006","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.bbr.2010.11.029_bib0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/07420529009056952","article-title":"Triazolam and phase-shifting acceleration re-evaluated","volume":"7","author":"Mrosovsky","year":"1990","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.bbr.2010.11.029_bib0135","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1517\/13543784.15.12.1545","article-title":"Are compounds acting at metabotropic glutamate receptors the answer to treating depression?","volume":"15","author":"Palucha","year":"2006","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.bbr.2010.11.029_bib0140","first-page":"757","article-title":"Effects of GABAB receptor ligands in rodent tests of anxiety-like behavior","volume":"59","author":"Partyka","year":"2007","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.bbr.2010.11.029_bib0145","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1124\/jpet.106.101287","article-title":"Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytics role for endogenous cannabinoid signaling","volume":"318","author":"Patel","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2010.11.029_bib0150","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.bbr.2010.11.029_bib0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2005.03.028","article-title":"Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats","volume":"514","author":"Pietraszek","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2010.11.029_bib0160","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1517\/14656566.2.4.681","article-title":"Citalopram: a comprehensive review","volume":"2","author":"Pollock","year":"2001","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.bbr.2010.11.029_bib0165","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.psyneuen.2004.08.008","article-title":"Affective responses to changes in day length in Siberian hamsters (Phodopus sungorus)","volume":"30","author":"Prendergast","year":"2005","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbr.2010.11.029_bib0170","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00008877-200111000-00011","article-title":"Comparison of the phenotype of NK1R\u2212\/\u2212 mice with pharmacological blockade of the substance P (NK1) receptor in assays for antidepressant and anxiolytics drugs","volume":"12","author":"Rupniak","year":"2001","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.bbr.2010.11.029_bib0175","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.brainres.2008.05.048","article-title":"Cannabinoids and hamster circadian activity rhythms","volume":"1222","author":"Sanford","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2010.11.029_bib0180","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.neuropharm.2007.01.007","article-title":"Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression","volume":"52","author":"Wesolowska","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2010.11.029_bib0185","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/339049a0","article-title":"Stimulated activity mediates phase shifts in the hamster circadian clock induced by dark pulses or benzodiazepines","volume":"339","author":"Van Reeth","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2010.11.029_bib0190","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0091-3057(95)02106-X","article-title":"Daily rhythms in spontaneous and diazepam-induced anxiolysis in Syurian hamsters","volume":"54","author":"Yannielli","year":"1996","journal-title":"Pharm Biochem Behav"},{"key":"10.1016\/j.bbr.2010.11.029_bib0195","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.euroneuro.2008.06.007","article-title":"The circadian basis of mood disorders: recent developments and treatment implications","volume":"18","author":"Monteleone","year":"2008","journal-title":"Eur Neuropsychopharm"},{"key":"10.1016\/j.bbr.2010.11.029_bib0200","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hup.964","article-title":"Circadian rhythm disturbances in depression","volume":"23","author":"Germain","year":"2008","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"10.1016\/j.bbr.2010.11.029_bib0205","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0301-0082(03)00087-X","article-title":"The neurobiology and control of anxious states","volume":"70","author":"Millan","year":"2003","journal-title":"Prog Neurobiol"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432810007540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432810007540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T18:23:56Z","timestamp":1544120636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432810007540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0166432810007540"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2010.11.029","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}